Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ding

Showing results (791-800 of 852) with videos related to

Pageof 86
Sort By:
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|September 27, 2025
[Efficacy and safety of immunotherapy combined with chemotherapy as conversion therapy for initially unresectable locally advanced esophageal squamous cell carcinoma]K L Lyu, M B Wang, C Y Gai, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 12, 2015
TBX21 polymorphisms are associated with virus persistence in hepatitis C virus infection patients from a high-risk Chinese populationD Y Zhu, L F Jiang, X Z Deng, et al.
Physical Review Letters|September 4, 2008
Anomalous transport properties and phase diagram of the FeAs-based SmFeAsO1-xFx superconductorsR H Liu, G Wu, T Wu, et al.
Journal of Endocrinological Investigation|February 15, 2024
Long-term prognostic value of thyroid hormones in left ventricular noncompactionL Liu, S Cai, A Chen, et al.
Oncogene|November 18, 2014
Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stabilityW Jiang, H Huang, L Ding, et al.
Leukemia|October 15, 2014
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicingT Okeyo-Owuor, B S White, R Chatrikhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie Ketas, et al.
Health & Place|August 28, 2025
Persistent effects of historical redlining on present day hospital siting and sizeShuo Jim Huang, Kaitlynn S Robinson-Ector, Neil Jay Sehgal, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 15, 2018
Circular RNAs and exosomes in cancer: a mysterious connectionJ Hou, W Jiang, L Zhu, et al.
Oncogene|March 21, 2017
CTCF genetic alterations in endometrial carcinoma are pro-tumorigenicA D Marshall, C G Bailey, K Champ, et al.
Pageof 86

Showing results (791-800 of 852) with videos related to

Sort By:
Pageof 86
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|September 27, 2025
[Efficacy and safety of immunotherapy combined with chemotherapy as conversion therapy for initially unresectable locally advanced esophageal squamous cell carcinoma]K L Lyu, M B Wang, C Y Gai, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 12, 2015
TBX21 polymorphisms are associated with virus persistence in hepatitis C virus infection patients from a high-risk Chinese populationD Y Zhu, L F Jiang, X Z Deng, et al.
Physical Review Letters|September 4, 2008
Anomalous transport properties and phase diagram of the FeAs-based SmFeAsO1-xFx superconductorsR H Liu, G Wu, T Wu, et al.
Journal of Endocrinological Investigation|February 15, 2024
Long-term prognostic value of thyroid hormones in left ventricular noncompactionL Liu, S Cai, A Chen, et al.
Oncogene|November 18, 2014
Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stabilityW Jiang, H Huang, L Ding, et al.
Leukemia|October 15, 2014
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicingT Okeyo-Owuor, B S White, R Chatrikhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie Ketas, et al.
Health & Place|August 28, 2025
Persistent effects of historical redlining on present day hospital siting and sizeShuo Jim Huang, Kaitlynn S Robinson-Ector, Neil Jay Sehgal, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 15, 2018
Circular RNAs and exosomes in cancer: a mysterious connectionJ Hou, W Jiang, L Zhu, et al.
Oncogene|March 21, 2017
CTCF genetic alterations in endometrial carcinoma are pro-tumorigenicA D Marshall, C G Bailey, K Champ, et al.
Pageof 86